Medical News

RSS

NYSE Amex grants PharmAthene extension to demonstrate listing compliance

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that based on information provided by PharmAthene in its compliance plan, and discussions with Exchange staff, the NYSE Amex LLC has determined that the Company made a reasonable demonstration of its ability to regain compliance with the NYSE Amex listing requirements and granted PharmAthene an extension until January 26, 2012 to demonstrate its compliance.

15 Oct 2010

Medicare actuary says changes in advantage plans will mean more cost for some seniors

Politico obtained an analysis by Richard Foster, the actuary for the Centers for Medicare and Medicaid, which that the health law will mean increased costs for seniors in Medicare Advantage plans.

15 Oct 2010

$Spinal fractures remain undiagnosed and untreated$

Spinal fractures remain undiagnosed and untreated

A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.

15 Oct 2010

UCSD certification for SynCardia temporary Total Artificial Heart to commence: SynCardia Systems

SynCardia Systems, Inc. announced today that the University of California, San Diego (UCSD), led by Stuart W. Jamieson, M.B., F.R.C.S. (photo), Head of Cardiothoracic Surgery, will begin certification to implant the SynCardia temporary Total Artificial Heart. Efforts to bring the Total Artificial Heart to UCSD were led by world renowned heart surgeon Dr. Jack Copeland, who joined the faculty in July.

15 Oct 2010

World Food Prize recipients call for investment in agriculture in developing countries

The 2010 World Food Prize recipients say despite the economic situation "it's no time for the United States to back off a historic pledge to invest in boosting the production of the world's poorest farmers," the Des Moines Register reports.

15 Oct 2010

UBM Medica acquires OBGYN.net from MediSpecialty.com

UBM Medica today announces that it has acquired the website OBGYN.net from MediSpecialty.com, Inc.

15 Oct 2010

Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar® Tablets, 25 mg, 50 mg and 100 mg, both antihypertensives.

15 Oct 2010

EntreMed receives letter from NASDAQ Stock Market

EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced that it has received a letter from the NASDAQ Stock Market indicating that it has regained compliance with the minimum $35 million Market Value of Listed Securities requirement for continued listing on the NASDAQ Capital Market as set forth in NASDAQ Marketplace Rule 5550(b)(2).

15 Oct 2010

Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Discovery Laboratories, Inc. today announces that the Phase 2a clinical study of aerosolized KL4 surfactant (lucinactant) in patients with cystic fibrosis (CF) has completed and the results from the study will be presented at the upcoming North American Cystic Fibrosis Conference (NACFC; October 21-23, 2010).

15 Oct 2010

Knopp Neurosciences forms new parent entity

Knopp Neurosciences Inc. announced today that it has formed a new parent entity called Knopp Biosciences LLC to expand operations with the goal of becoming a more broadly integrated biopharmaceutical company.

15 Oct 2010

CoreLab offers state-of-the-art imaging solutions for DXA imaging sciences

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).

15 Oct 2010

Political cartoon: "To The Moon"

Kaiser Health News provides a fresh take on health policy developments with "To The Moon" by Bob Englehart.

15 Oct 2010

New development of genetic tool to speed discovery of novel genes involved in cancer

Researchers have developed a genetic tool in mice to speed the discovery of novel genes involved in cancer. The system - called PiggyBac - has already been used by the team to identify novel candidate cancer-causing genes.

15 Oct 2010

Fluctuations in internal body temperature regulate body's circadian rhythm: Research

Researchers at UT Southwestern Medical Center have found that fluctuations in internal body temperature regulate the body's circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions.

15 Oct 2010

New implantable pressure sensor for patients with cataract and glaucoma

AcuMEMS, Inc. today announced the development of a new sensor for wireless intraocular pressure (IOP) monitoring of patients with co-incident cataract and glaucoma. Successful animal studies confirm the precise delivery of the implantable pressure sensor into the eye where synthetic intraocular lenses (IOL) are inserted for cataract treatment.

15 Oct 2010

First Edition: October 15, 2010

Today's top stories from major news organizations report on the effort by 20 states to challenge the federal health law, a new federal panel to inform consumers about health care options and the struggle to pay for cancer care.

15 Oct 2010

GI Dynamics' EndoBarrier therapy to treat type 2 diabetes and obesity granted European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. This approval is specific to up to 12 months of treatment with the EndoBarrier; the product has already received CE mark approval for three and six months of treatment. Through its commercial partner, Elemental Healthcare, GI Dynamics has also announced the launch of the EndoBarrier in the United Kingdom.

15 Oct 2010

Medical News

NYSE Amex grants PharmAthene extension to demonstrate listing compliance

Medicare actuary says changes in advantage plans will mean more cost for some seniors

Spinal fractures remain undiagnosed and untreated

UCSD certification for SynCardia temporary Total Artificial Heart to commence: SynCardia Systems

World Food Prize recipients call for investment in agriculture in developing countries

UBM Medica acquires OBGYN.net from MediSpecialty.com

Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs

EntreMed receives letter from NASDAQ Stock Market

Discovery Labs to present lucinactant Phase 2a clinical study results at NACFC Conference

Knopp Neurosciences forms new parent entity

CoreLab offers state-of-the-art imaging solutions for DXA imaging sciences

Political cartoon: "To The Moon"

New development of genetic tool to speed discovery of novel genes involved in cancer

Fluctuations in internal body temperature regulate body's circadian rhythm: Research

New implantable pressure sensor for patients with cataract and glaucoma

First Edition: October 15, 2010

GI Dynamics' EndoBarrier therapy to treat type 2 diabetes and obesity granted European CE mark approval

DAS acquires Excerpta Medica from Elsevier

Emerging Healthcare anticipates results of FDA-approved human embryonic stem-cell treatment

Neptune second quarter revenue increases 200% to $4,114,000

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News